Safety in human trials
Published reviews and trials that report adverse events and tolerability in people.
This page lists published studies. It reports what the authors did and found, with the limits of each study. It is not advice.
10 studies listed, newest first.
- Investigating Properties of Palmitoylethanolamide in Physiology and Disease: Far Beyond an Anti-Inflammatory ShieldReviewHumansOther animals
- Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populationsReviewHumans
- Palmitoylethanolamide in the Treatment of Pain and Its Clinical Application ProspectsReviewHumans
- Effect of Palmitoylethanolamide Compared to a Placebo on the Gut Microbiome and Biochemistry in an Overweight Adult Population: A Randomised, Placebo Controlled, Double-Blind StudyRandomised controlled trialHumans
- Extended Treatment with Micron-Size Oral Palmitoylethanolamide (PEA) in Chronic Pain: A Systematic Review and Meta-AnalysisMeta-analysisHumans
- Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled TrialsMeta-analysisHumans
- Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical EvidenceMeta-analysisHumans
- Tolerability profile of topical cannabidiol and palmitoylethanolamide: a compilation of single-centre randomized evaluator-blinded clinical and in vitro studies in normal skinControlled trialHumansTopicalWith cannabidiol
- Tolerability of Palmitoylethanolamide in a Pediatric Population Suffering from Migraine: A Pilot StudyOpen-label, no control groupHumans
- Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacyReviewHumans